#United States #Boston #Global Health #CeraVe #L'Oréal

Pioneering Investment in Global Health Dermatology

CeraVe, renowned as the top dermatologist-recommended skincare brand in the United States, has made a groundbreaking announcement in collaboration with Massachusetts General Hospital (MGH). Together, they have established the L'Oréal Dermatological Beauty/CeraVe Endowed Chair in Global Health Dermatology, marking a significant milestone for skin health initiatives worldwide. With this endowed chair, they aim to enhance access to dermatological care, particularly for underserved communities.

The recent event to celebrate this initiative saw Dr. Esther E. Freeman, a distinguished figure in global health dermatology, appointed as the first occupant of the Chair. Dr. Freeman’s role will focus on addressing the critical challenges faced by many due to skin diseases, which is currently a leading cause of disability globally. This unique collaboration highlights the dedication of CeraVe and MGH to their mutual mission of promoting skin health access for all. Dr. Freeman's experience and commitment to healthcare equity, particularly in sub-Saharan Africa, underscores the purpose of this initiative.

The Mission Behind the Endowed Chair

Skin diseases disproportionately impact vulnerable populations, leading to significant health disparities. The establishment of this endowed chair is a step towards tackling these inequalities and is tied to CeraVe's social impact program,